97-13920. Notice of Prospective Patent License

[Federal Register Volume 62, Number 102 (Wednesday, May 28, 1997)]
[Notices]
[Page 28898]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13920]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 97-074]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that Hyperthermia Technologies, Inc., 
of Plymouth, NM 55447, has applied for a partially exclusive license to 
practice the invention described and claimed in U.S. Patent No. 
5,261,874, entitled Extra-Corporeal Blood Access, Sensing, and 
Radiation Methods and Apparatus and U.S. Patent No. 5,429,594, entitled 
Extra-Corporeal Blood Access, Sensing, and Radiation Methods and 
Apparatus, which are both assigned to the United States of America as 
represented by the Administrator of the National Aeronautics and Space 
Administration. Written objections to the prospective grant of a 
license should be sent to the Johnson Space Center.

DATES: Responses to this notice must be received by July 28, 1997.

FOR FURTHER INFORMATION CONTACT:
James M. Cate, Patent Attorney, Johnson Space Center, Mail Code HA, 
Houston, TX 77058-3696, telephone [phone].

    Dated: May 20, 1997.
Edward A. Frankle,
General Counsel.
[FR Doc. 97-13920 Filed 5-27-97; 8:45 am]
BILLING CODE 7510-01-M